VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents (Q34273164)

1 August 2017

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents (English)

1 reference

1 August 2017

15

John C Bell

1 reference

1 August 2017

14

John Hiscott

1 reference

1 August 2017

1

David F Stojdl

1 reference

1 August 2017

2

Brian D Lichty

1 reference

1 August 2017

Benjamin R tenOever

3

1 reference

1 August 2017

Jennifer M Paterson

4

1 reference

1 August 2017

Anthony T Power

5

1 reference

1 August 2017

Shane Knowles

6

1 reference

1 August 2017

Ricardo Marius

7

1 reference

1 August 2017

Jennifer Reynard

8

1 reference

1 August 2017

Laurent Poliquin

9

1 reference

1 August 2017

Harold Atkins

10

1 reference

1 August 2017

Earl G Brown

11

1 reference

1 August 2017

Russell K Durbin

12

1 reference

1 August 2017

Joan E Durbin

13

1 reference

1 August 2017

1 October 2003

1 reference

1 August 2017

1 reference

1 August 2017

4

1 reference

1 August 2017

263-275

1 reference

1 August 2017

4

1 reference

Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Virus-induced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Oncolytic viruses: programmable tumour hunters

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Molecular analysis of genomic abnormalities in human gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Role of matrix protein in cytopathogenesis of vesicular stomatitis virus.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Genetic evidence for multiple functions of the matrix protein of vesicular stomatitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Different host-cell shutoff strategies related to the matrix protein lead to persistence of vesicular stomatitis virus mutants on fibroblast cells

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

The isolation of interferon-inducing mutants of vesicular stomatitis virus with altered viral P function for the inhibition of total protein synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Regulation of RANTES chemokine gene expression requires cooperativity between NF-kappa B and IFN-regulatory factor transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Oncolytic biotherapy: a novel therapeutic plafform

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Inhibition of Ran guanosine triphosphatase-dependent nuclear transport by the matrix protein of vesicular stomatitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Genome-wide analysis of RNA-protein interactions illustrates specificity of the mRNA export machinery

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Intra-rectal injection of tumour cells: a novel animal model of rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Toward a new generation of conditionally replicating adenoviruses: pairing tumor selectivity with maximal oncolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Recombinant vesicular stomatitis viruses from DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Whence interferon? Variety in the production of interferon in response to viral infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Multiple regulatory domains control IRF-7 activity in response to virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Regulation of the promoter activity of interferon regulatory factor-7 gene. Activation by interferon snd silencing by hypermethylation

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Potency of wild-type and temperature-sensitive vesicular stomatitis virus matrix protein in the inhibition of host-directed gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Preferential binding sites for interferon regulatory factors 3 and 7 involved in interferon-A gene transcription

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Gene induction pathways mediated by distinct IRFs during viral infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Oncolytic viruses and cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Large-population passages of vesicular stomatitis virus in interferon-treated cells select variants of only limited resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-beta gene

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Triggering the interferon antiviral response through an IKK-related pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Antiviral protection by vesicular stomatitis virus-specific antibodies in alpha/beta interferon receptor-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

The vesicular stomatitis virus matrix protein inhibits glycoprotein 130-dependent STAT activation

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

The complement response against an oncolytic virus is species-specific in its activation pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Effects of innate immunity on herpes simplex virus and its ability to kill tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3gamma.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Adenovirus-mediated gene transfer to orthotopic hepatocellular carcinomas in athymic nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

Inhibition of host transcription by vesicular stomatitis virus involves a novel mechanism that is independent of phosphorylation of TATA-binding protein (TBP) or association of TBP with TBP-associated factor subunits

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900241-1

7 January 2021

10.1016/S1535-6108(03)00241-1

Identifiers

DOI

1 reference

1 August 2017

1 reference